Michael C. Quinn

45.0k total citations
27 papers, 534 citations indexed

About

Michael C. Quinn is a scholar working on Molecular Biology, Reproductive Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Michael C. Quinn has authored 27 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Reproductive Medicine and 4 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Michael C. Quinn's work include Ovarian cancer diagnosis and treatment (6 papers), RNA modifications and cancer (5 papers) and RNA Research and Splicing (4 papers). Michael C. Quinn is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), RNA modifications and cancer (5 papers) and RNA Research and Splicing (4 papers). Michael C. Quinn collaborates with scholars based in Canada, United States and Australia. Michael C. Quinn's co-authors include Anne‐Marie Mes‐Masson, Diane Provencher, Patricia N. Tonin, Manon de Ladurantaye, Suzanna L. Arcand, Karen Gambaro, B. Craig, David F.M. Brown, Ali Filali‐Mouhim and Helen Mulholland and has published in prestigious journals such as The Journal of Immunology, PLoS ONE and Oncogene.

In The Last Decade

Michael C. Quinn

27 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael C. Quinn Canada	16	196	107	94	92	80	27	534
Alper Uzun United States	15	228 1.2×	65 0.6×	91 1.0×	59 0.6×	77 1.0×	52	637
Roland Matthews United States	17	269 1.4×	162 1.5×	70 0.7×	156 1.7×	96 1.2×	42	732
D. Stirling United Kingdom	14	206 1.1×	103 1.0×	153 1.6×	219 2.4×	91 1.1×	26	889
Johan Bjerner Norway	15	195 1.0×	111 1.0×	38 0.4×	148 1.6×	32 0.4×	30	681
Xufeng Wu China	11	219 1.1×	83 0.8×	44 0.5×	56 0.6×	139 1.7×	34	552
Julie Richer Canada	13	202 1.0×	40 0.4×	103 1.1×	40 0.4×	55 0.7×	34	670
Bo Yu China	14	303 1.5×	65 0.6×	156 1.7×	94 1.0×	56 0.7×	75	695
Yoo‐Kyung Lee South Korea	16	178 0.9×	163 1.5×	43 0.5×	217 2.4×	64 0.8×	32	707
Lei Yan China	14	188 1.0×	60 0.6×	95 1.0×	196 2.1×	114 1.4×	49	645
Mark D. Walsh United Kingdom	8	148 0.8×	130 1.2×	69 0.7×	106 1.2×	28 0.3×	13	547

Countries citing papers authored by Michael C. Quinn

Since Specialization

Citations

This map shows the geographic impact of Michael C. Quinn's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael C. Quinn with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael C. Quinn more than expected).

Fields of papers citing papers by Michael C. Quinn

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael C. Quinn. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael C. Quinn. The network helps show where Michael C. Quinn may publish in the future.

Co-authorship network of co-authors of Michael C. Quinn

This figure shows the co-authorship network connecting the top 25 collaborators of Michael C. Quinn. A scholar is included among the top collaborators of Michael C. Quinn based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael C. Quinn. Michael C. Quinn is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Best, Stephanie, C. Richards, Michael C. Quinn, et al.. (2024). Reanalysis of genomic data in rare disease: current practice and attitudes among Australian clinical and laboratory genetics services. European Journal of Human Genetics. 32(11). 1428–1435. 2 indexed citations

Mateos, Marion K., Glenn M. Marshall, Pasquale Barbaro, et al.. (2021). Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia. Haematologica. 107(3). 635–643. 29 indexed citations

Mateos, Marion K., Toby N. Trahair, Chelsea Mayoh, et al.. (2019). Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia. Thrombosis Research. 178. 132–138. 13 indexed citations

Haas, Matilda, et al.. (2019). The ethics approval process for multisite research studies in Australia: changes sought by the Australian Genomics initiative. The Medical Journal of Australia. 211(10). 440–440. 4 indexed citations

Moore, Kathleen N., David Tritchler, Kenneth M. Kaufman, et al.. (2017). Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study. Gynecologic Oncology. 147(2). 396–401. 3 indexed citations

Tilch, Erik, Michael C. Quinn, Adrian P. Wiegmans, et al.. (2015). Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib. PLoS ONE. 10(5). e0125232–e0125232. 24 indexed citations

Gambaro, Karen, Michael C. Quinn, Rebecca S. Shapiro, et al.. (2015). Low levels of IGFBP7 expression in high-grade serous ovarian carcinoma is associated with patient outcome. BMC Cancer. 15(1). 135–135. 20 indexed citations

Gambaro, Karen, Michael C. Quinn, Suzanna L. Arcand, et al.. (2013). VGLL3 expression is associated with a tumor suppressor phenotype in epithelial ovarian cancer. Molecular Oncology. 7(3). 513–530. 35 indexed citations

Quinn, Michael C., et al.. (2013). FKBP10/FKBP65 expression in high-grade ovarian serous carcinoma and its association with patient outcome. International Journal of Oncology. 42(3). 912–920. 26 indexed citations

10.

Oros, Kathleen Klein, Michael C. Quinn, Suzanna L. Arcand, et al.. (2012). The Genomic Landscape of TP53 and p53 Annotated High Grade Ovarian Serous Carcinomas from a Defined Founder Population Associated with Patient Outcome. PLoS ONE. 7(9). e45484–e45484. 33 indexed citations

11.

Quinn, Michael C., Lise Portelance, Nathalie Delvoye, et al.. (2012). Derivation and characterization of matched cell lines from primary and recurrent serous ovarian cancer. BMC Cancer. 12(1). 379–379. 52 indexed citations

12.

Gambaro, Karen, Manon de Ladurantaye, Michael C. Quinn, et al.. (2012). Overexpressing the CCL2 chemokine in an epithelial ovarian cancer cell line results in latency of in vivo tumourigenicity. Oncogenesis. 1(9). e27–e27. 12 indexed citations

13.

Quinn, Michael C., Abdelali Filali‐Mouhim, Diane Provencher, Anne‐Marie Mes‐Masson, & Patricia N. Tonin. (2009). Reprogramming of the transcriptome in a novel chromosome 3 transfer tumor suppressor ovarian cancer cell line model affected molecular networks that are characteristic of ovarian cancer. Molecular Carcinogenesis. 48(7). 648–661. 17 indexed citations

14.

Quinn, Michael C., Daniel J. Wilson, Adam A. Dempsey, et al.. (2009). The chemiluminescence based Ziplex® automated workstation focus array reproduces ovarian cancer Affymetrix GeneChip® expression profiles. Journal of Translational Medicine. 7(1). 55–55. 7 indexed citations

15.

Page, Cécile Le, Véronique Ouellet, Michael C. Quinn, et al.. (2008). BTF4/BTNA3.2 and GCS as Candidate mRNA Prognostic Markers in Epithelial Ovarian Cancer. Cancer Epidemiology Biomarkers & Prevention. 17(4). 913–920. 15 indexed citations

16.

Quinn, Michael C., et al.. (2007). Transcriptome analysis of serous ovarian cancers identifies differentially expressed chromosome 3 genes. Molecular Carcinogenesis. 47(1). 56–65. 23 indexed citations

17.

Cody, Neal, Véronique Ouellet, Michael C. Quinn, et al.. (2006). Transfer of chromosome 3 fragments suppresses tumorigenicity of an ovarian cancer cell line monoallelic for chromosome 3p. Oncogene. 26(4). 618–632. 37 indexed citations

18.

Quinn, Michael C., Philip A. Veillette, & Graham Young. (2003). Pseudobranch and gill Na+, K+-ATPase activity in juvenile chinook salmon, Oncorhynchus tshawytscha: developmental changes and effects of growth hormone, cortisol and seawater transfer. Comparative Biochemistry and Physiology Part A Molecular & Integrative Physiology. 135(2). 249–262. 17 indexed citations

19.

Smith, N. Ty, et al.. (1986). The effect of muscle movement on the electroencephalogram during anesthesia with alfentanil. The Journal of Clinical Monitoring. 2(1). 15–21. 4 indexed citations

20.

Lewis, F. John, et al.. (1972). Continuous patient monitoring with a small digital computer. Computers and Biomedical Research. 5(4). 411–428. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact